Skip to main content

Drug Manufacturers Specialty & Generic Stocks: Companies & Metrics

Browse 81 drug manufacturers specialty & generic stocks with financial metrics and performance data (Healthcare sector).

Industry market cap
$358.54B
Cap-weighted, today
+1.45%
Cap-weighted, 1 year
+34.93%
Advancing / declining today
43 / 36

Drug Manufacturers Specialty & Generic Stocks

81 stocks in the drug manufacturers specialty & generic industry. Click column headers to sort.

#
1
TAK logo
TAK
Takeda Pharmaceutical Company Limited$20.43$65.57B$29.41B$1.14B$0.412.56M
2
TEVA logo
TEVA
Teva Pharmaceutical Industries Limited$39.95$46.54B$17.40B$716.92M$0.615.94M
3
HLN logo
HLN
Haleon plc$10.20$45.55B$25.89B$3.81B$0.9719.91M
4
ZTS logo
ZTS
Zoetis Inc.$80.97$33.82B$9.52B$2.62B$6.084.14M
5
UTHR logo
UTHR
United Therapeutics Corporation$592.84$27.15B$3.15B$1.31B$27.86919.15K
6
VTRS logo
VTRS
Viatris Inc.$18.29$21.28B$14.74B-$410.70M−$0.359.18M
7
NBIX logo
NBIX
Neurocrine Biosciences, Inc.$145.87$15.20B$3.37B$705.50M$6.821.38M
8
ELAN logo
ELAN
Elanco Animal Health Incorporated$22.96$11.62B$5.02B-$199.00M−$0.405.36M
9
RDY logo
RDY
Dr. Reddy's Laboratories Limited$13.75$11.46B$3.48B$339.06M$0.413.09M
10
ALKS logo
ALKS
Alkermes plc$44.44$7.71B$1.67B$66.12M$0.392.36M
11
AMRX logo
AMRX
Amneal Pharmaceuticals, Inc.$21.02$6.90B$3.12B$157.36M$0.483.64M
12
LNTH logo
LNTH
Lantheus Holdings, Inc.$99.92$6.75B$1.56B$275.31M$4.121.04M
13
HIMS logo
HIMS
Hims & Hers Health, Inc.$27.59$6.39B$2.58B-$142.03M−$0.599.84M
14
KNSA logo
KNSA
Kiniksa Pharmaceuticals International, plc$72.98$6.09B$840.85M$80.66M$1.00630.21K
15
LQDA logo
LQDA
Liquidia Corporation$43.74$4.44B$450.91M$138.61M$1.435.48M
16
RGC logo
RGC
Regencell Bioscience Holdings Limited$6.76$3.34B$0.00-$8.90M−$0.02309.49K
17
AMLX logo
AMLX
Amylyx Pharmaceuticals, Inc.$27.09$3.01B$0.00-$152.09M−$1.491.37M
18
HCM logo
HCM
HUTCHMED (China) Limited$14.27$2.49B$549.12M$17.88M$0.1051.58K
19
BHC logo
BHC
Bausch Health Companies Inc.$6.35$2.40B$10.74B-$1.08B−$2.891.85M
20
SUPN logo
SUPN
Supernus Pharmaceuticals, Inc.$40.77$2.37B$830.44M-$109.89M−$1.91852.30K
21
PBH logo
PBH
Prestige Consumer Healthcare Inc.$48.15$2.29B$1.10B$172.01M$3.57601.32K
22
PRGO logo
PRGO
Perrigo Company plc$15.82$2.21B$4.14B-$1.73B−$12.492.75M
23
BCRX logo
BCRX
BioCryst Pharmaceuticals, Inc.$7.88$2.09B$940.61M-$384.67M−$1.635.46M
24
TRLV logo
TRLV
Trulieve Cannabis Corp.$10.82$2.09B$1.14B-$473.30M−$2.452.16M
25
XERS logo
XERS
Xeris Biopharma Holdings, Inc.$10.21$1.76B$335.41M-$17.16M−$0.103.07M
26
ETON logo
ETON
Eton Pharmaceuticals, Inc.$50.17$1.64B$105.59M$12.69M$0.41547.91K
27
PAHC logo
PAHC
Phibro Animal Health Corporation$39.03$1.60B$1.52B$99.72M$2.43232.96K
28
ANIP logo
ANIP
ANI Pharmaceuticals, Inc.$72.60$1.59B$978.38M$105.83M$4.93397.70K
29
PCRX logo
PCRX
Pacira BioSciences, Inc.$36.38$1.47B$746.16M$14.64M$0.351.95M
30
ALVO logo
ALVO
Alvotech$4.62$1.38B$491.95M-$179.59M−$0.561.23M
31
CRON logo
CRON
Cronos Group Inc.$3.31$1.24B$179.03M$69.73M$0.18870.94K
32
AMPH logo
AMPH
Amphastar Pharmaceuticals, Inc.$25.47$1.13B$730.02M$78.55M$1.69475.23K
33
HROW logo
HROW
Harrow, Inc.$28.95$1.08B$275.59M-$37.23M−$0.98631.62K
34
COLL logo
COLL
Collegium Pharmaceutical, Inc.$23.21$753.41M$808.21M$47.91M$1.26788.75K
35
IRWD logo
IRWD
Ironwood Pharmaceuticals, Inc.$3.50$585.13M$389.32M$129.87M$0.752.05M
36
AQST logo
AQST
Aquestive Therapeutics, Inc.$3.97$496.23M$54.09M-$78.23M−$0.652.19M
37
EOLS logo
EOLS
Evolus, Inc.$7.17$472.71M$316.49M-$34.33M−$0.53724.90K
38
KMDA logo
KMDA
Kamada Ltd.$7.94$459.63M$192.77M$22.33M$0.3892.76K
39
TLRY logo
TLRY
Tilray Brands, Inc.$2.72$362.69M$963.10M-$164.22M−$1.394.09M
40
TKNO logo
TKNO
Alpha Teknova, Inc.$6.59$353.45M$43.70M-$16.77M−$0.31557.79K
41
EBS logo
EBS
Emergent BioSolutions Inc.$6.34$327.14M$747.20M-$176.80M−$3.261.08M
42
ANIK logo
ANIK
Anika Therapeutics, Inc.$21.27$291.76M$120.65M-$3.78M−$0.2799.98K
43
CGC logo
CGC
Canopy Growth Corporation$0.67$282.11M$209.47M-$168.32M−$0.472.41M
44
EVO logo
EVO
Evotec SE$1.52$270.06M$901.15M-$158.01M−$0.51159.70K
45
LFCR logo
LFCR
Lifecore Biomedical, Inc.$6.44$241.98M$114.72M-$43.23M−$1.15584.47K
46
ACB logo
ACB
Aurora Cannabis Inc.$3.90$240.84M$205.42M-$19.58M−$0.34984.70K
47
SIGA logo
SIGA
SIGA Technologies, Inc.$3.16$226.79M$53.66M-$2.76M−$0.04579.42K
48
BIOA logo
BIOA
BioAge Labs, Inc.$4.99$223.75M$10.36M-$94.46M−$2.37856.54K
49
AKBA logo
AKBA
Akebia Therapeutics, Inc.$0.64$173.57M$219.06M-$29.67M−$0.118.09M
50
DERM logo
DERM
Journey Medical Corporation$4.97$136.64M$68.18M-$6.10M−$0.23203.28K
51
CRDL logo
CRDL
Cardiol Therapeutics Inc.$1.12$128.73M$0.00-$22.35M−$0.211.34M
52
OGI logo
OGI
Organigram Global Inc.$0.94$128.20M$220.55M$61.79M$0.46443.02K
53
ORGO logo
ORGO
Organogenesis Holdings Inc.$0.94$120.36M$456.92M-$94.20M−$0.73765.55K
54
TLPH logo
TLPH
Talphera, Inc.$1.07$80.81M$1.00K-$15.08M−$0.27120.99K
55
ZYBT logo
ZYBT
Zhengye Biotechnology Holding Limited$1.42$67.24M$17.45M-$10.47M−$0.221.17M
56
CPIX logo
CPIX
Cumberland Pharmaceuticals Inc.$4.35$65.17M$31.27M-$10.77M−$0.7265.57K
57
CTOR logo
CTOR
Citius Oncology, Inc.$0.60$64.27M$7.11M-$46.06M−$0.49122.16K
58
BGM logo
BGM
BGM Group Ltd.$8.40$51.97M$69.37M-$22.48M−$0.718.98K
59
SCYX logo
SCYX
SCYNEXIS, Inc.$3.81$45.05M$19.21M-$10.23M−$1.37396.41K
60
INCR logo
INCR
InterCure Ltd.$4.27$43.29M$87.88M-$11.61M−$1.084.35K
61
IXHL logo
IXHL
Incannex Healthcare Inc.$2.61$30.43M$12.00K-$29.59M−$2.5484.20K
62
RMTI logo
RMTI
Rockwell Medical, Inc.$7.00$27.71M$69.39M-$5.08M−$1.3225.32K
63
CPHI logo
CPHI
China Pharma Holdings, Inc.$0.63$25.72M$3.91M-$4.47M−$0.342.90M
64
AYTU logo
AYTU
Aytu BioPharma, Inc.$1.93$23.78M$57.57M-$14.25M−$1.0940.14K
65
TXMD logo
TXMD
TherapeuticsMD, Inc.$1.80$20.96M$3.27M-$217.00K−$0.0220.14K
66
OPTH logo
OPTH
Optimi Health Corp.$3.12$13.41M$125.32K-$4.92M−$1.4135.63K
67
BFRI logo
BFRI
Biofrontera Inc.$0.82$10.62M$46.17M-$6.37M−$0.54352.52K
68
CABR logo
CABR
Caring Brands, Inc.$1.08$9.71M$1.16K-$9.57M−$0.7525.26K
69
INM logo
INM
InMed Pharmaceuticals Inc.$1.59$7.47M$2.06B-$13.32M−$3.2662.55K
70
SHPH logo
SHPH
Shuttle Pharmaceuticals Holdings, Inc.$5.05$5.12M$0.00-$10.26M−$20.3342.45K
71
APUS logo
APUS
Apimeds Pharmaceuticals US, Inc.$2.90$4.96M$0.00-$58.48M−$50.297.68M
72
GELS logo
GELS
Gelteq Limited$0.45$4.69M$196.84K-$4.97M−$0.491.23M
73
SNOA logo
SNOA
Sonoma Pharmaceuticals, Inc.$1.12$4.31M$21.92M-$2.26M−$1.0145.47K
74
YCBD logo
YCBD
cbdMD, Inc.$0.36$3.87M$20.93M-$2.89M−$0.30324.93K
75
SBFM logo
SBFM
Sunshine Biopharma, Inc.$2.65$3.62M$35.35M-$5.83M−$8.34555.42K
76
SXTC logo
SXTC
China SXT Pharmaceuticals, Inc.$3.54$2.41M$2.54M-$7.37M−$6.72438.44K
77
RDHL logo
RDHL
RedHill Biopharma Ltd.$0.42$1.70M$9.55M-$9.31M−$4.25674.03K
78
UPC logo
UPC
Universe Pharmaceuticals INC$2.88$1.62M$37.04M-$852.71K−$3.0060.65K
79
PRFX logo
PRFX
PRF Technologies Ltd.$0.74$920.05K$39.50K-$8.90M−$8.88254.88K
80
AKAN logo
AKAN
Akanda Corp.$1.05$824.92K$1.09M-$49.67M−$1,386.191.03M
81
IMCC logo
IMCC
IM Cannabis Corp.$0.87$268.65K$32.67M-$12.95M−$5.285.71M

About the Drug Manufacturers Specialty & Generic Industry

The Drug Manufacturers Specialty & Generic industry includes 81 U.S.-listed companies in the Healthcare sector with a combined market capitalization of $358.54B. The largest are Takeda Pharmaceutical Company Limited (TAK, $65.57B), Teva Pharmaceutical Industries Limited (TEVA, $46.54B) and Haleon plc (HLN, $45.55B), together 44% of the industry's value.

24 of the 81 companies with reported earnings are profitable, and their median P/E ratio is 21.1. 8 of 81 pay a dividend, with a median yield of 2.18% among payers.

Over the past year the median stock is down 11.8%, and 33 of 80 are higher than a year ago. Median revenue growth is 6.3% year over year.

Weakest 1-year performers

Profitability

Profitable companies
24 of 81
Median gross margin
58.5%
Median net profit margin
-10.6%
Median return on equity
-12.4%

Longest dividend growth streak: Perrigo Company plc (PRGO), 22 consecutive years.

Frequently Asked Questions About Drug Manufacturers Specialty & Generic Stocks

How many stocks are in the drug manufacturers specialty & generic industry?

There are 81 publicly traded stocks in the drug manufacturers specialty & generic industry, part of the Healthcare sector.

Which drug manufacturers specialty & generic stocks pay the highest dividend yields?

The highest yields in the drug manufacturers specialty & generic industry are Perrigo Company plc (PRGO, 7.09%), Kamada Ltd. (KMDA, 5.43%) and Viatris Inc. (VTRS, 2.60%). Perrigo Company plc (PRGO) has the longest record of dividend increases, 22 consecutive years.

Which drug manufacturers specialty & generic stocks performed best over the past year?

Over the past year the strongest drug manufacturers specialty & generic stocks were Eton Pharmaceuticals, Inc. (ETON, +169.8%), Ironwood Pharmaceuticals, Inc. (IRWD, +119.0%) and Teva Pharmaceutical Industries Limited (TEVA, +111.4%). The weakest were Tilray Brands, Inc. (TLRY, −80.2%), Zoetis Inc. (ZTS, −44.0%) and Alvotech (ALVO, −41.2%).

Are drug manufacturers specialty & generic companies profitable?

24 of the 81 drug manufacturers specialty & generic companies with reported earnings are profitable, with a median gross margin of 58.5%, a median net profit margin of -10.6% and a median return on equity of -12.4%.